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Degradable Gelatin Microspheres as an
Embolic Agent: an Experimental Study in
a Rabbit Renal Model
Objective: To investigate the basic characteristics of degradable gelatin
microspheres (GMSs), including their embolic behavior and degradation periods
when they are used as embolic materials in the renal arteries of rabbit models.
Materials and Methods: Based on the GMS particle size, 24 kidneys were
divided into 3 groups of eight kidneys, and each group was embolized with a dif-
ferent GMS particle size (group 1: 35 100  m, group 2: 100 200  m, and group
3: 200 300  m). From each group, two rabbits were sacrificed immediately after
embolization (day 0), and a pair of rabbits from each group underwent an
angiogram and were sacrificed on days 3, 7, and 14, respectively, after emboliza-
tion. The level of arterial occlusion, the pathological changes in the renal
parenchyma, and the degradation of the GMSs were evaluated angiographically
and histologically. 
Results: A follow-up angiogram on days 0, 3, 7, and 14 revealed the presence
of wedge-shaped poorly-enhanced areas in the parenchymal phase as seen in all
groups. The size of these areas tended to increase with the particle diameter, and
persisted up to day 14. On days 3, 7, and 14, parenchymal infarctions were
observed histologically in all cases, and this observation corresponded with the
parenchyma being supplied by the embolized arteries. GMSs of group 1 mainly
reached the interlobular arteries, while those of group 3 mainly reached the inter-
lobar arteries. In all but two cases, the GMSs were identified histologically even
on day 14, and sequential degradation was histologically identified in all GMS
groups.
Conclusion: GMSs can be used as degradable embolic materials which can
control the level of embolization.
ranscatheter arterial embolization (TAE) has been widely accepted for its
efficacy and is used to treat various diseases, including tumors, vascular
lesions, and hemorrhages (1 3). Along with advances in this technique,
various embolic materials have been developed and utilized (4 7). Among these
materials, gelatin sponges are the most popular and are frequently used in Japan
because they are easy to handle and inexpensive. Additionally, other embolic materi-
als such as polyvinyl alcohol and trisacryl gelatin microspheres are not commercially
available in Japan (8). However, since gelatin sponges require manual cutting, the
sizes of the fragments are not uniform. Hence, it is impossible to intentionally select
the occlusion level of the vessels. Furthermore, although they are believed to degrade
in the vessels within a few weeks, the degradation periods of these sponges cannot be
strictly controlled (9, 10). 
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Tin 1987 for use as drug delivery systems (DDSs) (Fig. 1)
(11 16). Gelfoam powder (Upjohn, Tokyo, Japan) is
widely known as being composed of gelatin particles and is
commercially available.
However, since Gelfoam powder is made by simply
milling gelatin sponges, its shape is irregular and size is
varied. Therefore Gelfoam powder is not classified in the
category of microspheres (17). Moreover, as in the case of
Gelfoam, the degradation period of Gelfoam powder
cannot be controlled. 
In contrast, GMSs are manufactured by an entirely
different process. GMSs are spherical, and their degrada-
tion period and diameter can be controlled. These proper-
ties may be beneficial for their use as embolic materials.
Although Gelfoam can degrade completely within approxi-
mately one month in the extravascular tissue and within a
few weeks in the vascular space (9, 10, 18), whether or not
GMSs degrade more quickly within the vascular space than
in the extravascular space is unknown. Moreover, whether
or not the level of occlusion is controlled in parallel with
the size of GMSs is also unknown. This study aims at
determining the basic characteristics of GMSs, including
their embolic behavior and the degradation period when




Acidic gelatin (MW, 99 kDa) with an isoelectric point of
5.0 was obtained from Nitta Gelatin Co. Ltd., Osaka,
Japan. All other chemicals used were of the highest purity
available commercially.
Preparation of Gelalin Micorpheres
Gelalin micorpheres were prepared according to the
modified method of Tabata and Ikada (1989) by
glutaraldehyde crosslinking of an aqueous gelatin solution
dispersed in an oil phase in the absence of a surfactant
(12). In brief, 10 ml of acidic aqueous gelatin solution
(10%) that was preheated to 37 C was added dropwise
into 375 ml of olive oil (Wako Pure Chemical Industries,
Ltd., Osaka, Japan), and the mixture was stirred at 400 rev
min
1 at 37 C for 10 min to yield a water-in-oil (w/o)
emulsion. The stirring was continued for 30 min at 4 C,
and the microspheres that were formed were washed three
times with acetone (Wako Pure Chemical Industries, Ltd.,
Osaka, Japan) by centrifugation (5000 rev min
1, 5 min, 4
). After air drying, the microspheres were sized by
passing them through sieves with different apertures (35,
100, 200, and 300  m); they were then placed into 3
groups (group 1: 35 100  m, group 2: 100 200  m, and
group 3: 200 300  m) based on the sphere size.
The non-crosslinked dry GMSs were dispersed in 5 ml of
an aqueous glutaraldehyde solution (7.5 mg/ml, 25%,
NACALAI TESQUE Inc., Kyoto, Japan) at 4 for 15 hr
to facilitate crosslinking. The microspheres were further
agitated in 5 ml of 10 mM aqueous glycine solution
(NACALAI TESQUE Inc., Kyoto, Japan) at 37 for 1 hr
to block the residual aldehyde groups of the unreacted
glutaraldehyde. The resulting microspheres were finally
washed three times with double-distilled water by centrifu-
gation and were freeze-dried. The GMSs used in this
experiment were designed to degrade completely within
seven days in the extravascular tissues (19 and
unpublished data).
Embolization of the Renal Artery
The study protocol was approved by the Animal
Experimentation Committee, and the experiments were
performed according to the Animal Care Guidelines of
Shiga University of Medical Science. 
In this study, 24 kidneys of 18 female rabbits that
weighed 2.5 3 kg were used. Left kidneys were basically
used; however, right kidneys were also used when a left
kidney was not selected easily or when bilateral kidneys
were needed. These kidneys were divided into 3 groups-
group 1: GMSs of 35 100  m, n = 8; group 2: GMSs of
100 200  m, n = 8; and group 3: GMSs of 200 300  m, n
= 8-based on the diameter of the GMS particles used for
embolization.
General anesthesia was administered intramuscularly to
each rabbit by using medetomidine hydrochloride (0.1 mg
kg
1, Domitor; Meiji Seika Co., Ltd., Tokyo, Japan) and
ketamine hydrochloride (25 mg kg
1, Ketalar50; Sankyo
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Fig. 1. Microscopic appearance of gelatin microspheres (original
magnification,  100). Gelatin microspheres are spherical in
shape when dispersed in double-distilled water.Yell Yakuhin Co., Ltd., Tokyo, Japan). The right femoral
artery was surgically exposed, and a 4-Fr sheath (Clinical
Supply Co., Ltd., Gifu, Japan) was inserted using a cut-
down method under fluoroscopy. The trunk of the renal
artery was selected using a 4-Fr cobra-type catheter
(Clinical Supply Co., Ltd., Gifu, Japan), and renal arteriog-
raphy was performed by manual injection of 2 ml
Iopamidol (Iopamiron 370; Nihon Schering Co., Ltd.,
Osaka, Japan), diluted by 50%. The renal artery was
embolized immediately after the administration of a
mixture of 5 mg GMSs and 2 ml Iopamidol diluted by 50%. 
For each GMS group, angiographies were performed in
two kidneys immediately after the embolic procedure and
in two kidneys each on days 3, 7, and 14 after emboliza-
tion. The frequency at which sequential angiography was
performed for the same kidney during the course of the
experiment was as follows: 2 times, n = 10; 3 times, n = 4;
and 4 times, n = 1. In six kidneys, the angiographies were
performed only once during the observation period. The
sequential course of the angiography of each kidney is
presented in Table 1. 
Analysis
Immediately after the angiogram, the rabbits were
sacrificed by injecting the heart with an overdose of
pentobarbital (Nembutal; Dainippon Sumitomo
Pharmaceutical Co., Ltd., Tokyo, Japan), and the kidneys
were surgically removed. The sequential course of the
angiography and the sacrifice procedure followed for each
kidney are presented in Table 1. For one kidney in each
group, the rabbit was sacrificed immediately after the
embolization, i.e., no angiogram was performed. This was
done to observe the distribution of the GMSs immediately
after embolization, thus excluding the effect of the
angiographic procedure. Angiographies of renal artery
were analyzed on X-ray film. These analyses focused
mainly on the sizes of the poorly-enhanced areas. Since the
thickness of the renal cortex was approximately 7 mm as
seen on the X-ray film, poorly-enhanced areas with
diameters less than 7 mm were defined as embolized areas
of the interlobular artery. Therefore, poorly-enhanced
areas with diameters less than 7 mm were defined as small,
and those areas with diameters greater than 7 mm were
defined as large. The angiograms were interpreted by two
board-certified radiologists by consensus. 
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Table 1. Sequential Courses of Angiography ( ) and Sacrifice Procedure ( )The extracted kidneys were fixed in 10% formaldehyde
solution, processed, and embedded in paraffin. Coronal
histological sections were obtained, and hematoxylin and
eosin (H & E) staining was performed. The pathological
changes in the renal parenchyma and the level of the
artery occlusion, both of which were caused by the GMSs,
were evaluated based on the microscopic findings of the
specimens. The pathological analyses were mainly focused
on the ischemic changes in the renal parenchyma and the
secondary changes in the vessel wall. The level of the renal
artery occlusion caused by the GMSs was first categorized
as interlobar, arcuate, and interlobular, and it was then
evaluated. The occlusion level of the renal artery was
determined as follow; first, the arcuate artery was identi-
fied, since it coursed along the outer side of the renal
medulla. Second, the artery which coursed outer than the
arcuate artery was identified as the interlobular artery.
Third, the artery which coursed inner than the arcuate
artery was identified as the interlobar artery.
The degradation of the GMS particles within the vessel
was histologically evaluated using the following 4-point
grading scale. Grade 0: the original spherical shape and
size of the particle is maintained, or a slight deformation
and a small cleft or cavity formation are observed within
the particle without an obvious reduction in the particle
size. Grade 1: size reduction and distortion of the particle
and cleft or cavity formation within the particle are
moderately evident. Grade 2: size reduction and distortion
of the particle and the cleft or cavity formation are clearly
evident. Grade 3: GMSs are not observed in the
specimens. It is speculated that GMSs completely
degraded.
The histopathological analysis was preformed by two
radiologists by consensus, in consultation with a patholo-
gist.
RESULTS
Embolization Effect: Angiographic Findings
Embolization was successfully performed in all of the
rabbits. The mean diameter of the renal trunk was 2.0 mm
(range, 1.5 2.6 mm). The angiogram obtained immedi-
ately after embolization revealed that the nephrograms in
the parenchymal phase were heterogeneous, and wedge-
shaped poorly-enhanced areas were observed in four of
the 17 kidneys. A follow-up angiogram on each day
(performed 3, 7, and 14 days after embolization) revealed
the persistence of the wedge-shaped poorly-enhanced
areas in the parenchymal phase in all groups. The sizes of
the poorly-enhanced areas on the angiogram are
summarized in Table 2. In group 1, four out of six cases
showed small, poorly-enhanced areas in the follow-up
angiogram, although two out of six cases showed large
areas (Fig. 2A). Among the six cases in group 2, there was
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Table 2. Summary of the Angiographic and Pathological Findings
Group 1  1 2 3 4 5 6 7 8
Day after the  0 0 3 3 7 7 14 14
embolization
Size of the poorly large mainly mainly mainly  small mainly 
enhanced area small small small large
Occlusion level interlobular interlobar- interlobar- interlobar- interlobular arcuate- interlobular interlobar-
on the pathology interlobular interlobular interlobular interlobular interlobular
Group 2  9 10 11 12 13 14 15 16
Day after the  0 0 3 3 7 7 14 14
embolization
Size of the poorly small and large small and large mainly small and large small large
enhanced area in halves in halves large in halves
Occlusion level interlobar interlobar interlobular interlobar- arcuate- interlobar- interlobular interlobar-
on the pathology interlobular interlobular interlobular interlobular
Group 3 17 18 19 20 21 22 23 24
Day after the  0 0 3 3 7 7 14 14
embolization
Size of the poorly large large large large large large
enhanced area
Occlusion level interlobar interlobar interlobular interlobar- none interlobular interlobar- none
on the pathology arcuate interlobularone case of small ( 7 mm), poorly-enhanced areas; two
cases of large areas (> 7 mm); three cases of mixed-size
areas (< 7 mm or  7 mm) (Fig. 2B). In group 3, all cases
showed large areas (Fig. 2C). These areas were also
observed on day 14. 
Embolization Effect: Pathological Findings
The level of renal artery occlusion caused by the GMSs
was identified based on the pathological specimens; these
values and the sizes of the poorly-enhanced areas observed
in the angiograms are summarized in Table 2. It was
observed that immediately after embolization, the GMSs
of group 1 mainly reached the interlobular arteries, while
those of group 3 mainly reached the interlobar arteries
(Fig. 3). However, on days 3, 7, and 14, the GMSs with
larger diameters mainly occurred in the interlobular
arteries. In group 1, agglutinated GMSs that blocked the
vascular lumen occurred in the interlobar artery. On days
3, 7, and 14, parenchymal infarctions were observed in all
cases; these infarctions corresponded to the feeding areas
of the occluded arteries. Large infarctions were observed
in the cases in which the central arteries were occluded,
and these infarctions were observed on the angiogram as a
large poorly-enhanced area.
In all cases, the pathological specimens showed
leukocyte infiltration in the vascular walls throughout the
observation period, except immediately after emboliza-
tion. This infiltration was localized in the vessels where the
GMSs were lodged (Fig. 4). The degree of fibrosis was
more prominent on day 14 than on days 3 and 7. In group
Ohta et al.
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Fig. 2. Comparison of the sizes of the poorly-enhanced areas in
the angiogram of the parenchymal phase of the left renal artery
after embolization using different-sized gelatin microspheres. 
(A) group 1: 35 100  m; (B) group 2: 100 200  m; and (C) group
3: 200 300  m. 
The diameter of the poorly-enhanced areas was classified as large
(greater than 7 mm: arrowhead) or small (less than 7 mm: arrow).
In group 1 (A), the poorly-enhanced areas were small. Group 2 (B)
showed both small and large poorly-enhanced areas, and group 3
(C) showed only large poorly-enhanced areas. Thus, the poorly-
enhanced areas tended to increase with the diameter of the gelatin
microspheres.
CEmbolic Degradable Gelatin Microspheres in Rabbit Renal Model
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Fig. 3. Photomicrographic appearance of a resected kidney of group 1 (A) and group 3 (B) immediately after the embolic procedure.
It was observed that the gelatin microspheres in group 1 frequently reached the interlobular arteries (arrow in A), while those of group 3
reached the interlobar arteries (arrow in B). (Hematoxylin & Eosin staining; original magnification,  40)
AB
Fig. 4. Photomicrographic appearance of the secondary changes in the vessel walls of group 1. 
A. Severe infiltration of leukocytes (arrows) that surrounded the gelatin microspheres was observed in the arcuate artery on day 3.
Infarction of the renal parenchyma around this artery was demonstrated. 
B. Fibrosis (arrowheads) was observed in the wall of the interlobar artery around the gelatin microspheres on day 14; a decrease in the
number of leukocytes was also observed (arrow). These reactions were similar to those caused by Gelfoam. (Hematoxylin & Eosin
staining; original magnification,  100)
AB
Table 3. Grading of Gelatin Microspheres Degradation
Group 1  3 4 5678
Day after the embolization 3 3 7 7 14 14
Grade 0 0 1122
Group 2 11 12 13 14 15 16
Day after the embolization 3 3 7 7 14 14
Grade 0 0 1112
Group 3 19 20 21 22 23 24
Day after the embolization 3 3 7 7 14 14
Grade 0 0 31231, a fibrotic change was observed in the vascular wall at
the level of the interlobular artery even in the early stage
of the observation period. However, in group 3, a fibrotic
change was observed in the proximal portion of the renal
artery; in the late stage of the observation period; this
change tended to peripherally shift to the level of the
interlobular arteries. 
Degradation Period: Angiographic Findings
Sequential angiographic findings were obtained through-
out the experiment (14 days) for five kidneys in five cases
(cases 7, 15, 16, 23, and 24). In case 7 (group 1), the
interlobar arteries were reperfused to a greater extent on
day 14 than on day 7 (Fig. 5). In case 16 (group 2), the
interlobar arteries were reperfused to a greater extent on
day 14 than on day 3. However, no reperfusion of the
interlobar arteries was observed in cases 15 (group 2), 23
(group 3), and 24 (group 3).
Degradation Period: Pathological Findings
In all but two cases, the remnant GMSs could be
histologically identified even on day 14. However, as
shown in Table 3 and Figure 6, the sequential degradation
of the GMSs was clearly observed. On day 3 of follow-up,
the degradation level in all groups was found to be grade
0. On day 7 of follow-up, the degradation level observed
in most histological findings was of grade 1. The size of the
particles decreased, and mild distortion was observed.
Cleft or cavity formation was observed within the
particles. On day 14, it was observed that the size of the
Ohta et al.
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Fig. 5. Sequential left renal angiograms showing the reperfusion of
the interlobar arteries. (A) Angiogram immediately after the
embolization; (B) angiogram on day 7; and (C) angiogram on day
14. 
A. The angiogram conducted immediately after embolization
showed diffused poorly-enhanced areas of the renal parenchyma
in group 1. 
B. The angiogram on day 7 showed that the parenchymal
enhancement was restored, while the interlobar arteries were still
poorly visualized. Small poorly-enhanced areas (arrows) were also
found in the subcortical area. 
C. Angiogram on day 14 showed the recanalization of the interlo-
bar arteries (arrowheads) with few remaining small poorly-
enhanced areas (arrows). 
(case number: No. 7)
Cparticles had decreased continuously and their shape was
irregular. This sequential change was observed in all GMS
groups.
DISCUSSION
Of the various embolic materials, gelatin sponges are
most frequently used for TAE in Japan, particularly follow-
ing the chemolipiodolization procedure for hepatocellular
carcinoma, and to treat hemorrhage in various organs.
However, reperfusion is frequently observed within a few
weeks (9, 10). Although this is detrimental to emboliza-
tion, it is advantageous with regard to repeated TAE for
controlling tumor growth (8, 20). In such cases, repeated
TAE concomitant with anticancer drug therapy would be
effective. Reperfusion also contributes to the preservation
of normal tissue in the embolized area. However, gelatin
sponges must be cut or fragmented into small pieces with
scissors and graters; this process is time consuming, and the
size of the obtained particles is not uniform. The minimum
size of the obtained particles is usually limited to 500  m
(8). Thus, the success of TAE depends on the size of the
gelatin sponge particles and the hands-on skills of the
surgeon.
GMSs are available in a variety of sizes ranging from 10
to 500  m; an intentional size can be selected, and the
particles can be generated accordingly. Additionally, in
theory, the degradation period can be controlled to range
from 3 days to permanent by changing the degree of
crosslinking (19 and unpublished data). Thus, GMSs have
the potential to embolize vessels to an intentional
occlusion level if the appropriate particle size is selected;
further, GMSs can control the embolic period temporarily
to permanently, depending on the purpose. Tabata and
colleagues have also attempted to apply GMSs in a DDS in
the field of tissue engineering, and they have confirmed
that GMSs can release many agents such as basic fibroblast
growth factor in the target tissue (11 16). A variety of
Embolic Degradable Gelatin Microspheres in Rabbit Renal Model
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Fig. 6. Photomicrographic appearance of a resected kidney of
group 1 on day 3 (A), day 7 (B), and day 14 (C). (Hematoxylin &
Eosin stain; original magnification,  100)
A. Gelatin microspheres were completely solid and spherical, and
degradation was not observed (arrow). 
B. Gelatin microspheres were spherical; however, some cleft-like
cavities were found in the Gelalin micorphere particle (arrow). 
C. Gelatin microspheres were small and irregular in shape (arrow). 
Cphysiochemical interactions occur between GMSs and
these agents, and the agents can be released as the GMSs
degrade. If the GMSs are used as the embolic material
functioning as a DDS for the neoplasm, in theory, they will
be significantly efficient in releasing anticancer drugs and
in obliterating the feeding arteries to the intentional extent.
Knowing the degradation period will enable one to
prepare a time schedule for a repeated TAE and will facili-
tate the estimation of the degree of ischemic damage that
will occur in the normal tissue present in the embolized
area. In this study, based on the particle diameter, we
categorized GMSs into 3 groups-35 100  m, 100 200 
m, and 200 300  m. We evaluated the differences among
these groups with respect to the level of embolism in the
vessels and the effects observed from the sequential
angiographic and pathological findings. In this study, the
degradation period of the GMSs in the subcutaneous tissue
was set at seven days by controlling the degree of
crosslinking. However, as mentioned previously, the
degradation period of GMSs in the vascular space is
unknown. Another important issue that we encountered in
this study was whether the degradation period of the
GMSs in the extravascular space can be extrapolated to
those within the vascular space. The results of the
angiographic and pathological findings revealed that the
GMSs of all sizes had an adequate embolic effect. The size
of the poorly-enhanced areas seen on the angiogram
tended to increase with the particle diameter. It was also
revealed that the smaller GMSs could reach the peripheral
area. Further, it was pathologically proven that GMSs with
a diameter ranging from 35 100  m reached the interlob-
ular artery, while GMSs larger than 100  m were trapped
at the level of the interlobar artery; these findings
corresponded well with the angiographic findings.
However, in two of six cases in group 1, which had
particles of the smallest diameters, a large area of infarc-
tion was observed in the angiograms on all three days of
follow-up. This discrepancy cannot be explained appropri-
ately; however, our speculation is as follows. It is generally
known that the water repellency of smaller particles tends
to increase when dried particles are dispersed in water.
This is because the intermolecular force between the
particles is stronger than that between water molecules
(21). Consequently, GMSs smaller than 100  m tend to
remain undispersed in water. Moreover, based on our
experience, GMSs smaller than 100  m tend to agglutinate
easily even if they are well dispersed. The reason behind
this phenomenon is unclear. However, we hypothesize
that a variety of factors are intricately related, such as the
Derjaguin-Landau-Verwey-Overbeek (DLVO) theory,
which accounts for the dispersion and agglutination of the
molecules in water; the property of biopolymeric materi-
als; and the surface charge (22). It was speculated that to
prevent particle agglutination, the small GMS particles
should have been injected after adequately dispersing them
in a large amount of water. However, this injection method
may pose a disadvantage to the use of GMSs.
The pathological changes in the vascular wall that were
caused by the GMSs were similar to those caused by
Gelfoam. Goldstein and colleagues have reported that
Gelfoam embolization results in panarteritis that is charac-
terized by the infiltration of inflammatory leukocytes into
all the layers of the vessel wall as well as the disruption of
the intima and the elastic tissue (23). In this study, these
pathological changes were observed with GMSs of all sizes.
An inflammatory reaction was observed mainly in the
early observation phase; in the late phase, it changed to a
fibrotic reaction. However, the degree of these changes
was mild, and there was no significant difference in the
severity between the GMS particles and Gelfoam. 
The poorly-enhanced areas on the nephrograms
remained unchanged during the sequential observation.
This observation is probably related to the fact that the
renal artery is an end artery. Even if the GMSs
subsequently degraded after the embolization and reperfu-
sion of the vessel, renal infarction was already established
and irreversible. 
GMSs larger than 100  m were localized in the interlo-
bar arteries immediately after embolization; however, on
day 3, they were localized in the interlobular arteries.
These observations revealed that the GMSs gradually
migrated from the proximal to the distal portion of the
artery. This was not observed in the case of the GMSs of
35 100  m diameters because these particles had already
reached the level of the interlobular artery immediately
after embolization. 
From this study, we were unable to delineate the correct
degradation period of the GMSs in the vascular space.
Although the obtained results were inconclusive with
respect to the degradation period of GMSs, we observed
some important characteristics of GMSs within the vascular
space. First, it was confirmed that GMSs have the potential
to degrade within vessels. As observed, in the cases where
the GMSs were histologically identified within the vessels,
the particles in all GMS groups degraded sequentially.
Although the complete degradation period could not be
obtained during the 14 days of observation, most of the
GMS particles showed a high level of degradation after the
14-day observation period. It is speculated that the residual
particles will degrade completely in the subsequent one or
two weeks. Defining the exact degradation period within
the vessel will require extended angiographic and
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Further, it was proven that GMSs could persist in the
vessels for a longer period than that in the subcutaneous
tissue. The reason is speculated as follows. Gelatin is
known to be degraded by gelatin-degrading enzymes that
are widely distributed in body fluids (24). If the GMSs are
located within the subcutaneous tissue, they are easily
accessible to the gelatin-degrading enzymes. In contrast,
when the GMSs are impacted in the small vessels, particu-
larly in the end arteries (as in this study), the blood flow is
blocked; consequently, the interaction between the GMS
particles and the enzymes would be disturbed. In order to
prevent the occurrence of this phenomenon, an artery that
is not categorized as an end artery should be used in an
experimental study.
This study has the following limitations. First, the renal
artery was considered because it can be easily cannulated
and has a diameter suited to this experiment; however, as
described previously, the TAE for the renal artery cannot
be extrapolated to the general TAE for tumors, such as
those of the liver or the pelvic organ, because it is an end
artery without any collateral circulation. The occlusion of
the renal artery induces renal infarction without exception,
and this might influence the degradation period of the
GMSs. Ideally, to evaluate both the degradation period
and the embolic effect assuming a clinical condition, the
hepatic or internal iliac artery should be considered
because they are categorized as non-end arteries.
However, it is technically difficult to perform an
angiogram and embolization for the abovementioned
arteries in the rabbit model. A larger animal model would
be required for the execution of this experiment. Second,
although three types of GMSs-35 100  m, 100 200  m,
and 200 300  m in size-were used in this study, many
experimental results overlapped among the three groups.
In order to accentuate the differences between the groups,
the study should have been performed by narrowing the
diameter range and considering sizes such as 35 45  m,
100 120  m, and 250 300  m. Third, as described
previously, although the GMSs were observed in the
histological specimens on day 14 after the embolization,
the degradation period of the GMSs within the vessels
could not be precisely determined because the study was
scheduled only for 14 days. To resolve this issue, the
observation period should exceed 14 days. 
From this study, it was confirmed that GMSs have
sufficient potential to be used as embolic materials. If
GMSs of various sizes and degradation periods are made
commercially available in the future, a customized TAE
procedure can be designed by changing the level and the
period of occlusion. 
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